Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events / CONNOLLY S; YUSUF S; BUDAJ A; CAMM J; CHROLAVICIUS S; COMMERFORD P. J; FLATHER M; FOX K. A; HART R; HOHNLOSER S; JOYNER C; PFEFFER M; ANAND I; ARTHUR H; AVEZUM A; BETHALA-SITHYA M; BLUMENTHAL M; CEREMUZYNSKI L; R. DE CATERINA; DIAZ R; FLAKER G; FRANGIN G; FRANZOSI M. G; GAUDIN C; GOLITSYN S; GOLDHABER S; GRANGER C; HALON D; HERMOSILLO A; HUNT D; JANSKY P; KARATZAS N; KELTAI M; LANAS F; LAU C. P; LE HEUZEY J. Y; LEWIS B. S; MORAIS J; MORILLO C; OTO A; PAOLASSO E; PETERS R. J; PFISTERER M; PIEGAS L; PIPILLIS T; PROSTE C; SITKEI E; SWEDBERG K; SYNHORST D; TALAJIC M; TREGOU V; VALENTIN V; VAN MIEGHEM W; WEINTRAUB W; VARIGOS J. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 151(2006), pp. 1187-1193.
Titolo: | Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events |
Autori: | |
Data di pubblicazione: | 2006 |
Rivista: | |
Handle: | http://hdl.handle.net/11564/107250 |
Appare nelle tipologie: | 1.1 Articolo in rivista |